Double Blind Study for Effects of Donepezil Hydrochloride on Parkinson's Disease
Not Applicable
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000003080
- Lead Sponsor
- Clinical Research Center, Utano National Hospital, National Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects taking anti-cholinergic drugs, including trihexyphenidyl, biperidien, profenamine, piroheptine, metixene, mazaticol, promethazine, cyproheptadine. 2) Subjects with diffuse Lewy body disease (according to third report of the DLB consortium) . 3) Present or previous diagnosis of schizophrenia. 4) Severe liver dysfunction or severe renal dysfuction. 5) Present or previous diagnosis of sick sinus syndrome 6) Present or previous diagnosis of broncheal asthma. 7) Subjects who investigators judge as inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method